Emblem Corp Share Price

Stocks

EMC

CA29082J1084

Pharmaceuticals

End-of-day quote Toronto S.E. 19:59:45 18/03/2019 GMT 5-day change 1st Jan Change
1.880 CAD +1.62% Intraday chart for Emblem Corp +1.62% +106.59%

Valuation: Emblem Corp

Market Cap 248M 217M 199M 186M 352M 23.64B 358M 2.4B 930M 11.6B 932M 912M 39.96B P/E 2017
-16.3x
P/E 2018 -4.48x
Enterprise Value 219M 192M 176M 164M 311M 20.88B 316M 2.12B 821M 10.24B 823M 805M 35.28B EV / Sales 2017
72,352,077x
EV / Sales 2018 10,915,686x
Free-Float
98.36%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - 30/11/2017
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - 05/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+1.62% - - 0
+1.65%+3.41%-12.27%-7.09% 12.6B
+0.13%+1.75%-35.08%-59.56% 4.69B
+2.30%+7.71%-7.97%-11.88% 4.35B
+0.65%+1.44%+8.96%-39.86% 3.77B
+2.01%+5.82%+16.27%-12.90% 3.77B
-0.09%-12.55%-13.92%-22.73% 3.05B
+1.18%+1.33%-12.08%-5.17% 2.99B
+0.80%+1.27%-7.04%-26.27% 2.34B
+3.25%+6.45%-10.89%+28.39% 1.66B
Average +1.35%+3.76%-8.23%-17.45% 3.92B
Weighted average by Cap. +1.32%+4.10%-9.48%-18.33%

Financials

2017 2018
Net sales 2.69 2.35 2.16 2.02 3.82 256.47 3.89 26.03 10.09 125.8 10.12 9.9 433.46 8.22 7.19 6.6 6.15 11.66 782.83 11.86 79.44 30.79 383.97 30.88 30.2 1.32K
Net income -12.1M -10.57M -9.71M -9.05M -17.17M -1.15B -17.46M -117M -45.31M -565M -45.44M -44.45M -1.95B -24.26M -21.2M -19.47M -18.15M -34.41M -2.31B -34.99M -234M -90.83M -1.13B -91.09M -89.11M -3.9B
Net Debt -21.51M -18.8M -17.26M -16.1M -30.52M -2.05B -31.03M -208M -80.54M -1B -80.77M -79.02M -3.46B -29.05M -25.39M -23.31M -21.74M -41.21M -2.77B -41.91M -281M -109M -1.36B -109M -107M -4.67B
Logo Emblem Corp
Emblem Corp is a Canada-based Company engaged in alternative medicine sector. The Company is producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates in one segment, the production and sale of medical cannabis to patients who have received medical authorizations to acquire and use cannabis. The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as educating and also creating new forms of cannabinoid-based medication in standardized dosages. All of the Company’s assets are located in Canada.
Employees
-